Hemofiltration for Contrast-Induced Nephropathy

Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00158080

Enrollment

100

Registered

2005-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2005-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Catheterization, Chronic Kidney Disease

Brief summary

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Interventions

PROCEDUREhemofiltration

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with serum creatinine\>2.0mg/dl and/or GFR\<50ml/min

Exclusion criteria

* Emergent cardiac catheterization * Patients on chronic dialysis * Patients with HYHA\>III heart failure

Design outcomes

Primary

Measure	Time frame
Prevention of contrast-induced acute renal failure, Elevation of serum creatinine	—

Secondary

Measure	Time frame
Need for hemodialysis	—

Countries

Japan

Contacts

Primary ContactKoji Harada, MD

kzharada@naramed-u.ac.jp+81-744-22-3051

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026